2024-516574-30-00招募中1 期
Phase I trial of the new drug PhOx430 (inhibitor of the enzyme glucosaminyltransferase V) in patients with advanced solid tumors; first test of a drug of this class in human beings.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 149
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CEO/President
Scientific
Phost'In Therapeutics
研究点 (5)
Loading locations...
相似试验
终止
1 期
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal CancerColorectal CancerNCT05824559MEI Pharma, Inc.23
终止
1 期
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDSLeukemia, Myelogenous, AcuteMyelodysplastic SyndromesNCT01085656University of Florida18
已完成
1 期
Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate TabletsHealthyNCT06606860Swiss Tropical & Public Health Institute45
已完成
1 期
Phase 1 Study of Anti-OX40 in Patients With Advanced CancerAdvanced CancerNCT01644968Providence Health & Services30
招募中
1 期
Phase 1 dose-escalation trial of OMTX705, an anti-fibroblast activation protein antibody-drug conjugate, as single agent and in combination with anti-PD-1 in patients with advanced solid tumors2024-514746-36-00Oncomatryx Biopharma S.L.120